Life Sciences

Miller Thomson’s Life Sciences Group is intimately familiar with the highly specialized and complex regulatory environment in which life sciences companies operate. Our team brings together a broad depth of experience in the pharmaceutical product (prescription and non-prescription), biotechnology, medical device and natural health product businesses. Our team provides practical, efficient and creative solutions for the legal challenges encountered by life sciences companies.  Our services span Regulatory Affairs, Intellectual Property, Litigation, and Corporate.

Sorry. Your search returned no results. Please edit your search criteria and try again.

Sorry. Your search returned no results. Please edit your search criteria and try again.

Sorry. Your search returned no results. Please edit your search criteria and try again.

Displaying 1-1 of 1

Health Canada Releases Guidance on Tamper-resistance Formulations of Opioid Drugs

Prescription opioid drug abuse has been the focus of significant media attention in recent months.  The Minister of Health recently stated that she has asked her staff to work on a range of options to address Canada’s epidemic of opioid...

More

Displaying 1-1 of 1
Displaying 1-3 of 3

Thalmic Labs announces US$120 million Series B financing

Counsel to Thalmic Labs Inc.

More

Kapplex acquired by Miroculus in cross-border transaction

Counsel to Kapplex Inc.

More

Saskatoon-based health sciences companies placed into receivership

Counsel to a major creditor and contracting party to the Phenomenome companies

More

Displaying 1-3 of 3